Therefore, it can be surmised that mutant p53 mediated oncogenic gain-of-functions potentially drives dedifferentiation of cancer cells to cancer stem cells and vice-versa and underlies the enhanced tumorigenesis and poor prognosis of human cancers with p53 mutations. This evidence concerns the gene TP53 and cancer.